R&D Changing how the world finds new medicines: Physics modellin... Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.
Partner Content Partner Content Exclusive insights into the latest innovations at Drug Disco... Exclusive insights into the latest innovations
Partner Content Partner Content Invite from Roderick Hubbard, Vernalis Research chairing SMi... Invitation from Roderick E. Hubbard at DDC
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
